Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Voyager Therapeut (NQ: VYGR ) 7.000 +0.170 (+2.49%) Streaming Delayed Price Updated: 4:00 PM EDT, Nov 1, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Headline News about Voyager Therapeut < Previous 1 2 3 4 5 6 Next > 12 Health Care Stocks Moving In Tuesday's Intraday Session October 22, 2024 Via Benzinga In-Depth Examination Of 4 Analyst Recommendations For Voyager Therapeutics October 16, 2024 Via Benzinga Get “Picky” With Stocks For September Profits September 09, 2024 Via Talk Markets 3 High-Growth Stocks Poised To Double By Next Year August 28, 2024 The article outlines three high-growth stocks that could double by 2025, using specific screening criteria: strong buy ratings from multiple analysts, significant revenue and earnings growth, and... Via Talk Markets 7 Biotech Stocks to Buy for Their Game-Changing Potential August 08, 2024 Although the market may be reeling from the recent fallout, the red ink presents a viable opportunity in these biotech stocks. Via InvestorPlace What Analysts Are Saying About Voyager Therapeutics Stock July 31, 2024 Via Benzinga Is VOYAGER THERAPEUTICS INC (NASDAQ:VYGR) suited for growth investing? April 17, 2024 Should you consider VOYAGER THERAPEUTICS INC (NASDAQ:VYGR) for growth investing? Via Chartmill Is NASDAQ:VYGR a Fit for Growth Investing Strategies? March 27, 2024 High growth, ROE and relative strength for VOYAGER THERAPEUTICS INC (NASDAQ:VYGR), growth investors may appreciate this. Via Chartmill VYGR Stock Earnings: Voyager Therapeutics Beats EPS, Beats Revenue for Q2 2024 August 06, 2024 VYGR stock results show that Voyager Therapeutics beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024. Via InvestorPlace VYGR Stock Earnings: Voyager Therapeutics Beats EPS, Beats Revenue for Q1 2024 May 13, 2024 VYGR stock results show that Voyager Therapeutics beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024. Via InvestorPlace The Healthcare Bargain Blitz: 7 Undervalued Stocks to Inject into Your Portfolio March 27, 2024 With a possible rotation away from the technology space, these are the undervalued healthcare stocks to consider. Via InvestorPlace Delving into NASDAQ:VYGR's Growth Prospects. March 26, 2024 Why VOYAGER THERAPEUTICS INC (NASDAQ:VYGR) qualifies as a high growth stock. Via Chartmill Cheap Thrills: 7 Promising Value Stocks You Can Buy for Under $20 March 21, 2024 With so many thousands of securities available, there are bound to be compelling ideas for value stocks under $20. Via InvestorPlace Analyst Bullish On Gene Therapy-Focused Voyager Therapeutics Sees Best In Class Potential For Its Neurogenetic Medicine Platform March 19, 2024 Unlock potential with Voyager Therapeutics as HC Wainwright initiates coverage highlights its TRACER capsid platform, promising CNS-targeted gene therapies and strategic partnerships driving long-term... Via Benzinga Exploring NASDAQ:VYGR's growth characteristics. March 05, 2024 VOYAGER THERAPEUTICS INC (NASDAQ:VYGR) may be suited for growth investing, we'll explore why in this article. Via Chartmill Is VOYAGER THERAPEUTICS INC (NASDAQ:VYGR) suited for growth investing? March 05, 2024 Unlocking the Growth Potential of VOYAGER THERAPEUTICS INC (NASDAQ:VYGR). Via Chartmill Tech Stocks Set To Rise Thursday As January Inflation Data Fails To Scare Markets, Small Caps Surge February 29, 2024 Tech stocks drive pre-market surge, Fed inflation data fails to disrupt rate cut expectations. Futures up for Nasdaq, S&P 500, and small caps. Via Benzinga Topics Economy Stocks Exposures Interest Rates US Equities Why Okta Shares Are Trading Higher By Around 24%; Here Are 20 Stocks Moving Premarket February 29, 2024 Shares of Okta, Inc. (NASDAQ: OKTA) shares rose sharply in today’s pre-market trading after the company reported better-than-expected fourth-quarter financial results and Via Benzinga Voyager Therapeutics: Q4 Earnings Insights February 28, 2024 Via Benzinga Earnings Preview For Voyager Therapeutics February 27, 2024 Via Benzinga Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday February 29, 2024 It's time to dive into the biggest pre-market stock movers for Thursday as we check out all of the news affecting shares this morning! Via InvestorPlace 12 Health Care Stocks Moving In Wednesday's After-Market Session February 28, 2024 Via Benzinga 7 Under-the-Radar Biotech Stocks Gearing Up for Liftoff February 26, 2024 Although the health innovation space can be a risky environment, undervalued biotech stocks can take some of the edge off. Via InvestorPlace 5 Value Stocks To Watch In The Healthcare Sector February 05, 2024 Via Benzinga Earnings Scheduled For February 28, 2024 February 28, 2024 Companies Reporting Before The Bell • ICL Group (NYSE:ICL) is likely to report quarterly earnings at $0.08 per share on revenue of $1.69 billion. Via Benzinga Financial Frontrunners: 3 Stocks Where the Big Money Is Moving in 2024 January 11, 2024 The 2024 investment trends are slowly making themselves known. Make sure you follow our guide to stay ahead of the curb. Via InvestorPlace A Look Into Healthcare Sector Value Stocks January 08, 2024 Via Benzinga Why Applied Therapeutics Shares Are Trading Lower By Over 35%? Here Are Other Stocks Moving In Friday's Mid-Day Session January 05, 2024 Shares of Applied Therapeutics, Inc. Via Benzinga 12 Health Care Stocks Moving In Friday's Pre-Market Session January 05, 2024 Via Benzinga Why Dermata Therapeutics Shares Are Trading Higher By Over 57%; Here Are 20 Stocks Moving Premarket January 05, 2024 Shares of Dermata Therapeutics, Inc. (NASDAQ: DRMA) rose sharply in pre-market trading after the company announced the issuance of a new patent in Japan for its DMT410 program for the treatment of... Via Benzinga Topics Intellectual Property Exposures Intellectual Property < Previous 1 2 3 4 5 6 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
